De Meo Daniele, Martini Paolo, Pennarola Maria Francesca, Guarascio Giovanni, Rivano Capparuccia Marco, Iaiani Giancarlo, Candela Vittorio, Gumina Stefano, Villani Ciro
Department of Anatomical, Histological, Forensic Medicine and Orthopaedics Sciences, Sapienza University of Rome, 00100 Rome, Italy.
M.I.T.O. (Malattie Infettive in Traumatologia e Ortopedia-Infections in Traumatology and Orthopedics Surgery) Study Group, Policlinico Umberto I Hospital, Viale del Policlinico 155, 00161 Rome, Italy.
Gels. 2023 Sep 18;9(9):758. doi: 10.3390/gels9090758.
Periprosthetic joint infections (PJI) are among the most difficult complications to treat in orthopaedic surgery. Debridement, antibiotics, and implant retention (DAIR) represent an efficient strategy for acute PJI, especially when resorbable local antibiotic carriers and coatings are used. The aim of this pilot study was to evaluate the difference between using antibiotic-loaded hydrogel (ALH) and calcium sulphate (CS) beads in the DAIR procedure. We analysed 16 patients who had been treated since 2018 for acute PJI, namely eight patients with knee PJI (50%), seven with hip PJI (43.7%), and one with shoulder PJI (6.2%). Nine patients were treated with the Debridement, Antibiotic Coating and Retention of the Implant (DACRI) method, while seven were treated with the Debridement, Antibiotic Pearls, Retention of the Implant (DAPRI) method. We found no significant differences between the two groups in terms of age, sex, the American Society of Anesthesiologists risk score, Charlson Comorbidity Index, localisation, days from onset to diagnosis and pathogenesis. Furthermore, no differences were found between the DACRI and DAPRI groups in terms of infection control (15 patients, 93.75% with = 0.36) and last C-Reactive Protein values ( = 0.26), with a mean follow-up of 26.1 ± 7.7 months. Treatment for one patient affected by knee Candida albicans PJI in the DACRI group was not successful. In conclusion, DAPRI and DACRI appear to be safe and effective treatments for PJIs. This evidence will encourage the development of new clinical research into local carriers and coatings for use in acute implant-associated infections.
人工关节周围感染(PJI)是骨科手术中最难治疗的并发症之一。清创、使用抗生素和保留植入物(DAIR)是治疗急性PJI的有效策略,尤其是在使用可吸收的局部抗生素载体和涂层时。这项前瞻性研究的目的是评估在DAIR手术中使用载抗生素水凝胶(ALH)和硫酸钙(CS)珠之间的差异。我们分析了自2018年以来接受急性PJI治疗的16例患者,即8例膝关节PJI患者(50%)、7例髋关节PJI患者(43.7%)和1例肩关节PJI患者(6.2%)。9例患者采用清创、抗生素涂层和保留植入物(DACRI)方法治疗,7例患者采用清创、抗生素珠、保留植入物(DAPRI)方法治疗。我们发现两组在年龄、性别、美国麻醉医师协会风险评分、Charlson合并症指数、感染部位、从发病到诊断的天数和发病机制方面没有显著差异。此外,DACRI组和DAPRI组在感染控制(15例患者,93.75%,P = 0.36)和末次C反应蛋白值(P = 0.26)方面没有差异,平均随访时间为26.1±7.7个月。DACRI组中1例受白色念珠菌膝关节PJI感染的患者治疗未成功。总之,DAPRI和DACRI似乎是治疗PJI的安全有效方法。这一证据将鼓励开展新的临床研究,探索用于急性植入物相关感染的局部载体和涂层。